In August 2021, Medicare Plus Ltd, a local drug company manufactured the A+Solution, which is a new drug targeting the common flu virus.

The drug had been through laboratory testing and was first tested at the local hospital and mysteriously cured over 100 patients, whom have had common cold and flu tablets in the past with no success.

The Government was convinced that this new drug would help alleviate its budget constraints and requested Medicare Plus Ltd to produce more supplies for the local hospital and supply overseas.

Medicare Plus Ltd paused and requested your advice on whether this new drug could be patented under Intellectual Property Rights Law.

Discuss with reference to a country of your choice, how you would advise Medicare Plus Ltd.

Refer to case laws and relevant statutes to support your advice.